Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist-Reference-Cited by-同舟云学术

Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist

Published:2008-09-09 Issue:3 Volume:327 Page:736-745
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Iglarz Marc,Binkert Christoph,Morrison Keith,Fischli Walter,Gatfield John,Treiber Alexander,Weller Thomas,Bolli Martin H.,Boss Christoph,Buchmann Stephan,Capeleto Bruno,Hess Patrick,Qiu Changbin,Clozel Martine

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs

2. Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction

3. Combined Endothelin Receptor Blockade Evokes Enhanced Vasodilatation in Patients With Atherosclerosis

4. The pharmacology of bosentan

5. The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Cited by 290 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of cyclic sulfamides via one pot alkylation/aza-Michael cascade reaction;Tetrahedron Letters;2024-09

2. Real-world effectiveness and safety of macitentan in patients with pulmonary artery hypertension: a multicenter, retrospective, observational study in China;Current Medical Research and Opinion;2024-08

3. Structural basis of antagonist selectivity in endothelin receptors;Cell Discovery;2024-07-30

4. Extra domain A-containing fibronectin in pulmonary hypertension and treatment effects of a function-blocking antibody;Cardiovascular Research;2024-07-18

5. Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease;Current Opinion in Nephrology & Hypertension;2024-06-19